1.
Ultra low-cost artificial leg developed
HAWTHORNE, N.Y., March 3 (UPI) -- Acorda Therapeutics said Friday it has completed enrollment in its phase 3 study of multiple-sclerosis drug Fampridine SR.
The company is studying the drug in more than 200 MS patients to test the drug's effectiveness in improving walking ability.
Secondary outcomes of the trial include measurements of leg strength and muscle spasticity, Acorda said.
The company said it should have data from the study by the third quarter of this year.
Fampridine-SR, licensed from Irish drug maker Elan, showed in phase 2 studies to improve walking speed in MS patients.
Acorda also announced it has more than doubled its sales force for Zanaflex Capsules -- approved for the management of spasticity -- with a continued focus on the neurology, physical medicine and rehabilitation markets.
Acorda earlier this month completed a $33 million initial public offering, issuing 5.5 shares of common stock at $6 per share, according to reports.
|
|
|
|
|
|
| Additional Health News Stories | |
WASHINGTON, Feb. 10 (UPI) --
Republican presidential contender Mitt Romney told a conservative audience in Washington Friday he would make sweeping changes to Medicare and Social Security.
|
NEW YORK, Feb. 10 (UPI) --
U.S. recording stars Jay-Z and Beyonce have posted photos of their 4-week-old daughter at HelloBlueIvyCarter.tumblr.com.
|
Police: One-legged man hid cocaine in butt ... Man sent pictures of stolen panties ... Company tattoos hair onto bald men ... Artist slims down Renaissance paintings ... UPI Quirks in the News.
|
BAGHDAD, Feb. 10 (UPI) --
Iran has been plundering oil from southern Iraq, a theft on a grand scale that's helping Tehran withstand sanctions aimed at throttling its oil exports.
|
| Stories | Photos | People | Comments |
View Caption
